Founded in 1998, REVA Medical is dedicated to developing interventional medical devices that leverage the Companys novel stent designs and biomaterials to improve the treatment of vascular disease.
The Companys flagship product is a bioresorbable coronary stent that is designed to fulfill the temporary need for a stent and then fade away, leaving only the healed vessel behind. This product promises to revolutionize the treatment of coronary artery disease.
The Company is also developing an ultra-thin balloon expandable nickel titanium stent and radiopaque, bioresorbable embolic beads for the treatment of uterine fibroids and other applications.
REVA Medical has a broad strategic relationship with Boston Scientific Corporation, a worldwide developer and marketer of interventional medical devices. The Company is also certified to the ISO 13485:2003 standard.